Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 448 followers

Latest posts

Last updated about 18 hours ago

Innovation Task Force (ITF) briefing meeting request form

about 22 hours ago

Innovation Task Force (ITF) briefing meeting request form

PSUSA/00000732/202512

1 day ago

PSUSA/00000732/202512

PSUSA/00001088/202512

1 day ago

PSUSA/00001088/202512

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation...

Electronic product information (ePI)

1 day ago

Electronic product information (ePI)

PSUSA/00011041/202510

1 day ago

PSUSA/00011041/202510

How to pay

1 day ago

How to pay

How to pay fees and charges levied by EMA: Guidance to marketing authorisation holders and applicants

1 day ago

How to pay fees and charges levied by EMA: Guidance to marketing...

SEPA Direct Debit B2B: Guidance for marketing authorisation holders and applicants

1 day ago

SEPA Direct Debit B2B: Guidance for marketing authorisation holders and applicants

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation...

Tackling antimicrobial resistance: Information for animal health practitioners

2 days ago

Tackling antimicrobial resistance: Information for animal health practitioners

Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 4, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation...